1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6986DEE4E4D396296852577EC002959A4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/986DEE4E4D396296852577EC002959A4!OpenDocument
18
19OpenDocument
203.236.222.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Planning and Coordinating Launch Communication Activities

Complimentary Excerpt: Onglyza Case Study: Lack of Differentiation Mutes a Launch

DB Image

ID: MD-221


Features:

Metrics, Graphics


Pages/Slides: 4


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".


To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5109 "Onglyza Case Study: Lack of Differentiation Mutes a Launch."


Industries Profiled:
Pharmaceutical


Companies Profiled:
Bristol-Myers Squibb; AstraZeneca

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.